Department of Health and Human Services Public Health Service, Grant Application

FF Principal Investigator/Program Director (Last, first, middle): Raabe, O.G.
Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, J. L. Wiedmann, J. W. Pensyl, J. H. Ross, A. P. Leber, and P. Jones, P. MixerLoader-Applicator exposure and percutaneous absorption studies involving EPTC herbicide. Chapter 22. In: Wang,
R. G. M., C. A. Franklin, R. C. Honeycut, and J. C.Reinert (eds.), Biological Monitoring for Pesticide Exposure:
Measurement, Estimation,and Risk Reduction, American Chemical Society, Washington, DC., pp. 288-303, 1989.
Al-Bayati, M. A. Toxicokinetics and toxicity of vanadate in rats. Ph.D. Thesis, Comparative Pathology, University of
California, Davis, CA, 1989.
Al-Bayati, M. A., S. N. GirinO. G. Raabe, L. S. Rosenblatt, and M. Shifrine. Time and dose-response study of the effects of
vanadate on rats: morphological and biochemical changes in organs. J. Environ. Pathol. Toxicol. Oncol. 9:(5) 435-455,
1989.
Al-Bayati, M. A., S. N. Giri and O. G. Raabe. Time and dose-response study of the effects of vanadate on rats: Changes in
blood cells and serum elements. J. Environ. Pathol. Toxicol. Oncol. 10(4-5): 206-213, 1990.
Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. In vivo percutaneous absorption studies in rat:
Pharmacokinetics and modeling of isofenphos absorption. In Scott, R. C. (ed), Prediction of Percutaneous Penetration:
Methods, Measurements, and Modelling,. IBC Technical, England, 1990.
Al-Bayati, M. A., O. G. Raabe, S. N. Giri, and J. B. Knaak. Distribution of vanadate in rat following subcutaneous and oral
exposure. J. Am. Coll. Toxicol. 10(2): 233-241, 1991.
Al-Bayati, M. A., M. R. Culbertson, J. P. Schreider, L. S. Rosenblatt, and O. G. Raabe. The lymphotoxic action of vanadate.
J. Environ. Pathol. Toxicol. Oncol. 11(2): 19-27, 1992.
Knaak, J. B., M. A. Al-Bayati and O. G. Raabe. Physiologically-based pharmacokinetics modeling to predict tissue dose
and cholinesterase inhibition in workers exposed to organophosphorus and carbamate pesticides.
In Health Risk Assessment Through Dermal and Inhalation Exposure and Absorption of Toxicants, G.M. Wang, J.B.
Knaak, and H.I. Maibach (eds.), pp 3-29. CRC Press, Boca Raton, FL, 1992.
Al-Bayati, M. A., O. G. Raabe and S. V. Teague. Effect of inhaled dimethylselenide in the Fisher-344 male rat. J. Toxicol.
Environ. Health 37: 549-557, 1992.
Knaak, J. B., M. A. A1-Bayati, 0. G. Raabe and J. N. Blancato. Development of in vitro Vmax and Km values for the
metabolism of isofenphos by P-450 liver enzymes in animal and human. Journal of Toxicology and Applied
Pharmacology, 120:106-113,.1993.
Gospe, S.A., and M.A. Al-Bayati. Comparison of Oral and Inhalation Exposures to Toluene. American College of
Toxicology, 1993 (In Press).
Raabe, O.G., D.W. Wilson, M.A. Al-Bayati, W.J. Hornof and L.S. Rosenblatt. Biological effects of inhaled pollutant
aerosols. Presented at the Seventh International Symposium on Inhaled Particles, Scotland, U.K., September, 1991.
Paper #5.1. (In Press).
Patents (application submitted):
Al-Bayati, M. A, Raabe, O. G., and Teague, S. "Skin Decontamination for Animals Exposed to Radioactive and Toxic
Substance or Infected with Parasites", Patent pending, University of California, Case # 89-013-1, 1989.
AI-Bayati, M. A. "Use of Drugs to Prevent the Development of Fibrotic Lesions in Organs," Patent pending, University of
California, case # 91-253-1, 1991.

PHS 398 (Rev. 9/91) (Form Page 6) Page 15 FF
Number pages consecutively at the bottom throughout the application Do not use suffixes such as 3a, 3b.